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Abstract 
Background: Moringa stenopetala and related species are commonly used in folk medicine for various human 
diseases such as antimalarial, antihypertensive, antidiabetic and as antispasmodic.  
Objective: The aim of the study is to evaluate the effects of aqueous extract of M. stenopetala on blood parameters, 
and histopathology of liver and kidney in experimental mice. 
Methods: Fresh leaves of M. stenopetala were collected from Arbaminch area, Southwest Ethiopia, in November 
2005. The leaves were dried and extracted with water. Three month-old Swiss albino male mice, which were kept 
under uniform laboratory conditions, were randomly divided into four groups (one group of controls and three 
experimental). (The control group was orally given 0.5 ml of distilled water, and groups II, III and IV were given the 
aqueous leaf extract of M. stenopetala using intragastric tube to achieve the required doses of 600, 750 and 900 mg/kg 
body weight, respectively once a day at 24 hours intervals for six weeks and then sacrificed). Blood sample was 
collected from each mouse and examined for hematological and biochemical parameters. Liver and kidney were 
removed, stained and examined for histopathological profiles. The effects of treatment with aqueous extract of M. 
stenopetala on hematological, biochemical and histopathology features were compared with control group following 
standard procedures.  
Results: Mice treated with 900 mg/kg of the extract per kg of body weight showed a significant increase in body 
weight compared to the controls (P=0.014). Neither a significant change in the weight nor in histopathology of liver 
and kidney were observed in the animals treated with aqueous extract of M. stenopetala compared to those of the 
controls. Serum glucose level (P=0.034) and serum cholesterol level (P=0.016) decreased significantly after six weeks 
treatment.  
Conclusion: The aqueous leaf extract of M. stenopetala is shown to increase body weight and reduce serum glucose 
and cholesterol level in mice. This indicates nutritional and medicinal values, but we cannot yet recommend its 
therapeutic use before more and complete studies are done.  [Ethiop J Health Dev. 2011;25(1):51-57] 
 
Introduction 
Moringa stenopetala, a smooth barked deciduous tropical 
plant, is a traditional medicinal and nutritional plant in 
Ethiopia (1). It is widely distributed in the southwestern 
part of Ethiopia at an altitude range of about 1100 to 
1600 meters. The major growing areas are Arbaminch, 
Negelle and Wellayta Sodo. M. stenopetala is commonly 
called Shiferaw in Amharic (2). M. stenopetala and 
related species (M. oleifera) are commonly used in folk 
medicines as antimalarial, antihypertensive, against 
stomach pain, antidiabetic, anticholesterol, antispasmodic 
and to expel retained placentae during birth (1 - 6).  
 
The active constituents in the leaves of M. stenopetala 
and related species such as M. oleifera (Behen) are 
glucosinolates; e.g., 4-(alpha –L-rhamnosyloxy) benzyl 
glucosinolate which yield 4-(alpha-L-rhamnosyloxy) 
benzyl isocyanate following enzymatic degradation with 
myrosinase. Phenol carboxylic acids and fatty acids 
including oleic acid (60 to 70%), palmitic acid (3-12%) 
stearic acid (3-12%) as well as eicosanoic acid and 
lignoceric acid in addition to mustard oil are other 
constituents. The antimicrobial effect of M. stenopetala 
leaves and of related species is related to the secondary 
metabolite constituents (7, 8). 
 
Documentation on the use of M. stenopetala in the southern 
regions of Ethiopia has shown that the leaves of Shiferaw 
are cooked and eaten, for example, with the traditional 
kurkufa (cereal preparation from maize and sorghum). The 
people of Konso and the surrounding communities in 
southern Ethiopia rely on the plant both as food and to treat 
various ailments (2, 9). Fresh leaf extracts of M. 
stenopetatla showed some oxytocic-like activity on 
guinea-pig ileum and mouse uteri (1). To date, the effect 
of M. stenopetala aqueous leaf extract on blood 
parameters and on the histopathology of liver and kidney 
have not been studied. Therefore, the aim of the present 
study is to evaluate the effects of M. stenopetala on some 
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blood parameters, and histopathology of liver and kidney 
in laboratory-bred mice. 
 
Methods  
The study was conducted in the Department of Anatomy, 
Faculty of Medicine and Aklilu Lemma Institute of 
Pathobiology (ALIPB), Addis Ababa University (AAU). 
 
Plant Material Collection and Preparation 
Fresh leaves of M. stenopetala were collected from Arba 
Minch area, about 500 km south of Addis Ababa, 
Ethiopia, in November 2005. Plant sample was identified 
by the National Herbarium of Addis Ababa University. 
The leaves were cleaned from any extraneous materials, 
dried at room temperature and ground to powder. The 
powder was mixed with water in Erlenmeyer flasks and 
placed in an orbital shaker at room temperature for 24 
hours. The mixture was then filtered with cotton and 
Whatman filter paper (15.0 cm size). The filtrates were 
freeze-dried in a lyophilizer to yield a crude extract. 
From 388 g dry leaf, which was dissolved in a total of 
1940 ml of distilled water, 40 g (10.31%) of crude extract 
was obtained. The crude extract was kept in a refrigerator 
at -20oC until used. 
 
Experimental Animals and Treatment 
Twenty adult (3 months old) Swiss albino male mice 
weighing 25-27 g were used. They were bred in the 
animal house of ALIPB, Addis Ababa University by 
placing one male to two female mice in a cage. They 
were kept under uniform laboratory conditions and 
exposed to 12 hrs of light and 12 hrs of darkness. The 
animals were provided with free access to pellets and 
allowed to drink tap water ad libitum throughout the 
duration of the experiment. The mice were randomly 
divided into four groups with each group consisting of 
five mice. Group I served as a control and each mouse 
was orally administered with 0.5 ml of distilled water. 
Groups II, III and IV were given the extract to attain the 
required doses of 600, 750 and 900 mg/kg body weight 
respectively, once a day at 24 hours intervals for six 
weeks. The standard WHO procedure for evaluation of 
herbal medicine for toxicity studies was adopted (10). 
The doses were selected based on the results of 
preliminary experiments. The extract was administered 
with intragastric tube according to the animal’s body 
weight. The animal’s weight was recorded at the 
beginning and end of the experiment. 
 
Hematological and Biochemical Analysis 
With light ether anesthesia, blood samples (2.0-3.5 ml) 
were withdrawn by cardiac puncture. Hematological 
analysis for white blood cell count, red blood cell count, 
platelet count, hematocrit, hemoglobin, mean corpuscular 
volume, mean corpuscular hemoglobin, and mean 
corpuscular hemoglobin concentration and lymphocytes 
was made using a hematology analyser (Sysmex KX-21N 
Auto Hematology Analyzer, KOBE, JAPAN). Glucose, 
urea, uric acid, cholesterol, triglycerides and creatinine 
were measured using an autohumalyser (Autohumalyser 
900Splus Human, Germany). Sodium, potassium, and 
chloride ions were determined by an electrolyte analyzer 
(9180 Electrolyte Analyzer, Roche, Germany). Total 
protein was analyzed by refractometry (Refractometery, 
American Optical Company, U.S.A).  
 
Liver and Kidney Weights 
Immediately after the blood withdrawal the mice were 
sacrificed and dissected. Liver and kidney were removed 
and weighed on a microbalance sensitive to 0.001mg 
(Precisa 125A, Switzerland) and recorded. Data were 
expressed per 100 g body weight.  
 
Light Microscopic Preparation 
For light microscopic preparation, the whole of the right 
kidney and the lower one centimeter long part of the right 
lobe of the liver in coronal and transverse pieces, 
respectively, were dissected, fixed in 10% formalin for 
24 hours, dehydrated in a graded ethanol series, cleared 
in xylene, infiltrated and embedded in paraffin. Thin 
sections (5 µm) were cut using a microtome (Leica RM 
2125, Leica Microsystems Nussloch GmbH, Germany) 
and stained with hematoxylin and eosin. The preparation 
was examined under light microscope (Leitz, Wetzlar, 
Germany). Photomicrographs of selected samples of the 
liver and kidney tissue were then taken with TMX 200 
film under x10, x25 and x40 objective using a Leitz 
Dialux 20 Wild Photo Automat MPS 51. Following the 
evaluation of the control animals, the liver and kidney 




All the values in the test are presented as mean and 
standard error of the mean (mean ± SEM). Statistical 
differences between the means of various groups were 
evaluated by one-way analysis of variance (ANOVA) 
followed by Student’s t-test using SPSS version 13 
program. P-values <0.05 were considered significant. 
 
Results 
Mice treated with 900 mg of the extract per kg of body 
weight showed significant increase in their body weight 
compared to the controls (P=0.014). However, there was 
no significant change in the body weight of mice treated 
with doses of 600 and 750 mg/kg when compared to the 
control groups. No significant change in the weight of 
liver and kidney was observed in the entire group 
(Table1). 
 
There was no significant difference in the hematological 
composition of the blood parameters between the control 
group treated with 600 mg/kg, 750 mg/kg and 900 mg/kg 
(P>0.05) (Table2). As shown in Table 3, glucose 
(P=0.034) and cholesterol (P=0.016) decreased 
significantly after treatment with 600 mg/kg, 750 mg/kg 
and 900 mg/kg M. stenopetala compared to that of the 
control group. 
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Table 1:  Body and organ weights of mice after treatment with M. stenopetala extract 
 Relative organ weight 
(g/100g bw) 
Group Treatment (mg/kg/bw) Initial body weight (g) Final body weight (g) Liver Kidney 
 
 
I Control (dis. water) 26.38 ± 0.69 28.64 ± 1.95 4.12 ± 0.10 0.71 ± 0.23 
 
II 600 26.46 ± 0.52 32.44 ± 1.05 4.24 ± 0.35 0.74 ± 0.34 
 
III 750 27.14 ± 0.72 33.88 ± 2.79 4.26 ± 0.32 0.77 ± 0.35 
 
IV 900 26.46 ± 0.72 40.90 ± 2.97* 4.34 ± 0.42 0.79 ± 0.41 
Values are mean ± SEM. *P<0.05, N=5/group 
Keys: SEM, standard error of the mean; g, gram; bw, body weight; mg, milligram; kg, kilogram; diss., distilled 
 
Table 2:  Hematological analysis of mice after treatment with M. stenopetala extract 
Values are mean ± SEM. P<0.05, N=5/group 
Keys: WBC, white blood cell count; RBC,  red blood cell count; HCT, hematocrit; HGB, hemoglobin; MCV, mean 
corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration. 
 
Table 3:  Biochemical analysis of mice after treatment with M. stenopetala extract 







  Treatment groups (mg/kg bw) 
Hematological parameters Control (diss. water) 600 750 900 
WBC x 103/ µl 
 
4.40 ± 0.21 5.10 ± 0.23 5.10 ± 0.71 5.66 ± 0.53 
RBC x 106/ µl 7.91 ± 0.92 8.52 ± 0.49 8.09 ± 0.52 8.55 ± 0.28 
 
Platelets x 103/ µl 396.75 ± 27.02 397.05 ±12.05 389.07 ± 120.05 399.06 ± 112.67 
 
HCT (%) 48.22 ± 1.58 48.62 ± 1.41 48.44 ± 1.96 48.04 ± 1.25 
 
HGB (g/dl) 10.70 ± 1.00 10.62 ± 0.93 10.50 ± 0.60 10.80 ± 0.32 
 
MCV (fl) 84.10 ± 1.47 82.56 ± 0.88 82.42 ± 0.51 85.78 ± 1.70 
 
MCH (pg) 28.24 ± 0.55 28.20 ± 0.54 28.80 ± 0.22 28.70 ± 0.24 
 
MCHC (g/dl) 32.74 ± 1.42 32.38 ± 1.10 33.44 ± 0.48 32.80 ± 0.39 
 
Lymphocytes (%) 40.74 ± 3.70 39.74 ± 2.95 44.66 ± 3.42 46.18 ± 2.91 
  Treatment groups (mg/kg bw) 
Biochemical  parameters Control (DW) 600 750 900 
Glucose (mg/dl) 152.30 ± 47.06 125.40 ± 12.07* 121.80 ± 13.46* 135.40 ± 8.78* 
 
Urea (mg/dl) 52.02 ± 4.83 47.60 ± 2.61 49.20 ± 2.99 49.60 ± 2.31 
 
Creatinine (mg/dl) 0.78 ± 5.83 0.80 ± 5.47 0.80 ± 0.11 0.80 ± 5.48 
 
Total protein (mg/dl) 6.80 ± 0.37 6.52 ± 0.32 6.72± 0.32 6.70 ± 0.46 
 
Uric acid (mg/dl) 6.80 ± 0.37 6.52 ± 0.32 6.72 ± 0.32 6.70 ± 0.46 
 
Cholesterol (mg/dl) 134.60 ± 15.09 119 ± 9.10* 118.60 ± 8.50* 113.20 ± 5.07* 
 
Triglycerides (mg/dl) 165.80 ± 26.50 163.40 ± 16.18 164.20 ± 40.76 167.40 ± 39.79 
 
Na+ (mmol/l) 125.80 ± 5.35 128.80 ± 5.30 133.00 ± 4.38 131.20 ± 5.48 
 
K+ (mmol/l) 8.30 ± 0.24 7.36 ± 0.78 7.36 ± 0.62 7.48 ± 0.62 
 
Cl- (mmol/l) 123.00 ± 2.41 123.60 ± 2.91 121.80 ± 3.07 121.20 ± 3.93 
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Light microscopic observation with the doses of 600 
mg/kg, 750 mg/kg and 900 mg/kg of M. stenopetala 
showed no marked histopathological changes on the 
livers and kidneys of mice as compared to the control 
group (Figs. 1 and 2). The liver and kidney histology of 
the control mice showed characteristic features showing 
normal central vein lined by endothelial cells, radiating 
hepatic cells and hepatic sinusoids (Fig. 1A) and 
Bowman’s capsule lined with outer parietal layer 
(squamous capsular cells) and inner visceral layer 
(podocyte cells), urinary space, proximal convoluted 
tubules, distal convoluted tubules, macula densa, vascular 




Figure 1:  Photomicrographs of liver of untreated (control) mouse liver (A) (H and E, x25). (B) Mice treated with 
600 mg/kg bw of M. stenopetala leaf extract. (H and E, x25). (C) Mice treated with 750 mg/kg bw of M. 
stenopetala leaf extract. (H and E, x25). (D) Mice treated with 900 mg/kg bw of M. stenopetala leaf extract (H and 
E, x25)  
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Figure 2:  Photomicrographs of kidney of untreated (control) mouse kidney (A) (H and E, x40). (B) Mice treated 
with 600 mg/kg bw of M. stenopetala leaf (H and E, x40). (C) Mice treated with 750 mg/kg bw of M. stenopetala 
leaf extract (H and E, x40). (D) Mice treated with 900 mg/kg bw of M. stenopetala leaf extract (H and E, x40). 
G = Glomerulus, Curved arrow = Squamous cell, p= Podocytes, u= Urinary space, t= Proximal convoluted 
tubule, D= Distal convoluted tubule, arrow head= Macula densa, V= Vascular pole. 
 
Discussion 
In this study, the effects of long-term treatment with M. 
stenopetala aqueous leaf extract on some hematological 
and biochemical parameters of the blood, and 
histopathology of liver and kidney were investigated.  
 
Treatment with different doses of the extract was well 
tolerated by all the animals, as there were no toxic effects 
observed by direct visual observation of the animals 
throughout the experiment. There was no death and 
apparent behavioral changes recorded during the course 
of the experiment in all treatment groups as compared to 
the control group. This might suggest the non-toxic effect 
of the extract (11). The rate of food and water intake of 
the mice given 600, 750 and 900mg/kg doses of M. 
stenopetala aqueous leaf extract was comparable with 
those of the control group. In previous experiments it was 
established that M. stenopetala was not toxic even at 
higher doses; showing why the plant is edible. 
 
Mice treated with a dose of 900 mg/kg bw of M. 
stenopetala aqueous leaf extract showed statistically 
significant increase from 26.46 + 0.72 g to 40.90 + 2.97 g 
in their body weight (P=0.014). The increase in weight 
might be due to the fact that M. stenopetala is a good 
source of nutrition. This is in agreement with the 
previous studies done somewhere else (12, 13), who 
reported that M. stenopetala contains important nutrients 
such as vitamins, proteins, minerals, carbohydrates and 
fats. It was also reported that calcium is essential at all 
ages irrespective of physiological status of individuals 
and for the normal development of skeletal system (14, 
15).  
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There was a slight increase in liver and kidney weight 
ratio of mice treated with doses of 600, 750 and 
900mg/kg bw as compared to the control group although 
it was not statistically significant (P>0.05). This might be 
because of the presence of glucosinolate in M. 
stenopetala aqueous leaf extract (7, 16, 17), as has been 
described that rats fed with diets containing six-
individual glucosinolates produce small increase in the 
weights of liver and kidneys.  
 
In this study, blood glucose levels of mice treated with 
600, 750 and 900mg/kg bw M. stenopetala decreased 
significantly from 152.30 + 47.06 to 125.40 + 12.07, 
121.80 + 13.46 and 135.40 + 8.78, mg/dl respectively 
(P=0.034). This is in agreement with the findings of 
Jaiswal et al. (18), who reported that blood glucose level 
decreased after administration of M. oleifera aqueous leaf 
extract to rats. This may suggest that M. stenopetala may 
have an insulin-like effect on peripheral tissues either by 
promoting glucose uptake and metabolism or by 
inhibiting gluconeogenesis. It is likely that the aqueous 
extract of the leaves has some effect of increasing the 
tissue utilization of glucose (19, 20) by inhibiting hepatic 
gluconeogenesis or absorption of glucose into the 
muscles and adipose tissues (21).  
 
Similarly, mice treated with doses of 600, 750 and 900 
mg/kg bw of M. stenopetala aqueous leaf extract had 
significantly decreased their blood cholesterol level from 
134.60 + 15.09 to 119.60 + 9.10, 118.60 + 8.50 and 
113.20 + 5.07, respectively, in a dose dependant-manner 
(P=0.016). This is in agreement with the study reported 
for Moringa oleifera leaf extract that showed 
hypocholesterolemic activity (22, 23). It was reported 
that the mechanism of cholesterol reduction is thought to 
be through the lowering of plasma concentrations of LDL 
by B-sitosterol, the bioactive phytoconstituent isolated 
from Moringa oleifera (22, 24, 25).  Therefore b- 
sitosterol or a similar constituent in the leaves of M. 
stenopetala may be responsible for this effect as well. 
However, the extract did not show significant change 
(P>0.05) on urea, creatinine, total protein, uric acid, 
triglycerides, Na+, K+ and Cl- as compared to the control 
group. This might be an indication of the non-toxic 
action of M. stenopetala on the body metabolism of the 
mice. 
 
In addition, mice treated with all the doses of M. 
stenopetala aqueous leaf extract did not show any 
morphological changes in the liver cells. This is in 
agreement with the in vitro cytotoxicity study done by 
Mekonnen et al., (26), who reported that an aqueous 
extract of leaves from M. stenopetala on hepatocytes did 
not affect cell viability. Furthermore, no significant 
histopathological changes were observed in the kidneys 
of the mice treated with all doses. This might be 
substantiated by the results of biochemical parameters of 
the blood, such as urea and creatinine which are the main 
indicators of kidney damage (27-31). Since none of these 
pathological symptoms were observed in all the mice 
investigated, M. stenopetala leaf extracts might not have 
adversely affected the kidneys. 
 
In conclusion, this study showed that treatment of mice 
with the aqueous leaf extract of M. stenopetala showed 
that there was body weight increase in the mice and that 
there were no after adverse effects observed. From 
previous work on M. stenopetala  showing the 
availability of important nutrients (12, 13) and medicinal 
value (1, 2), further studies are warranted to fractionate 
the active principle and find out the mechanism(s) of 
action of M. stenopetala leaf extract on blood glucose 
and cholesterol levels in animal models to ascertain its 
therapeutic importance.  
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